Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Linear IgA disease: a heterogeneous disease

F Wojnarowska¹, J Allen, P Collier

¹Department of Dermatology, Churchill Hospital, Oxford, UK.

Dermatology (Basel, Switzerland)

|January 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

The British journal of dermatology·2017

Same author

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

The British journal of dermatology·2017

Same author

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Same author

Response to Letter by Prof. C.B.B. Bunker.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Same author

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Same author

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

Clinical and experimental dermatology·2016

Same journal

Survey on Difficult to Treat Tinea: A Sub-Saharan Africa Snapshot.

Dermatology (Basel, Switzerland)·2026

Same journal

Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges.

Dermatology (Basel, Switzerland)·2026

Same journal

Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study.

Dermatology (Basel, Switzerland)·2026

Same journal

Descriptive Analysis of DRESS Reports from EudraVigilance and DRESS Cases from the RegiSCAR-project.

Dermatology (Basel, Switzerland)·2026

Same journal

The Role of the Vagus Nerve and Its Stimulation in Modulating Inflammatory Skin Diseases and Other Dermatologic Conditions: From Mechanisms to Therapeutics.

Dermatology (Basel, Switzerland)·2026

Same journal

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Dermatology (Basel, Switzerland)·2026

See all related articles

Linear IgA disease shows significant heterogeneity in clinical presentation, target antigens, and immunogenetics. Research reveals distinct patient subgroups with varying disease characteristics and genetic associations.

Area of Science:

Immunodermatology
Autoimmune Blistering Diseases
Molecular Genetics

Background:

Linear IgA disease (LAD) is a rare autoimmune blistering condition.
Previous studies suggest potential heterogeneity, but comprehensive characterization is lacking.

Purpose of the Study:

To investigate the heterogeneity of linear IgA disease regarding clinical features, target antigens, and immunogenetics.
To identify distinct patient subgroups within LAD.

Main Methods:

Analysis of clinical data from 70 patients.
Immunohistochemical studies using split skin and cylindroma substrate to identify target antigens.
HLA and tumor necrosis factor alpha (TNF-α) allele typing.

Main Results:

Related Experiment Videos

Clinical presentation varied in age of onset, skin/mucosal involvement, and scarring.
Two distinct target antigens were identified: an epidermal/hemidesmosome-associated antigen and a dermal antigen resembling collagen VII.
Association with HLA-B8, -DR3, Cw7, and a rare TNF-α allele was observed in a subset of patients, but not universally.
No correlation was found between clinical, antigenic, and immunogenetic differences.

Conclusions:

Linear IgA disease is a heterogeneous condition with distinct clinical, antigenic, and immunogenetic profiles.
These findings suggest different pathogenetic mechanisms may underlie LAD subtypes.
Further research is needed to elucidate the clinical implications of these observed differences.